Zoladex 3.6 mg contains goserelin in a sustained-release implant presented in a prefilled syringe with a protective SafeSystem needle sleeve.
Each box contains one depot implant (3.6 mg) for subcutaneous administration, typically scheduled every 28 days according to the treatment plan set by the prescriber.
This is a prescription medicine and should be used only under clinical supervision; store below 25°C and keep out of reach of children.
